Literature DB >> 17010424

Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles.

Alexia Grandjean-Laquerriere1, Olivier Tabary, Jacky Jacquot, Doriane Richard, Patrick Frayssinet, Moncef Guenounou, Dominique Laurent-Maquin, Patrice Laquerriere, Sophie Gangloff.   

Abstract

Hydroxyapatite (HA) is widely used to coat metal parts in order to improve their biocompatibility. Analysis of retrieved tissues associated with failed implants, suggest that phagocytosis of HA wear debris by monocytes/macrophages might provide a potent stimulus for the release of a variety of cytokines. Phagocytosis involved a large variety of cellular receptors like toll-like receptors that results in activation of the transcriptional nuclear factor-kappaB (NF-kappaB) via a cell-signalling pathway. In the present paper, we aimed to evaluate the role of the toll-like receptor 4 (TLR4) in the production of inflammatory cytokines induced by HA particles using TLR4(+) and TLR4(-) peritoneal macrophages. We investigated the production of TNF-alpha and the activation of the nuclear transcription factor NF-kappaB. Our data clearly show for the first time that the production of TNF-alpha by macrophages exposed to HA particles was TLR4 dependent but not the activation of NF-kappaB. All these results open future therapies to reduce the inflammatory response induced by HA biomaterials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010424     DOI: 10.1016/j.biomaterials.2006.09.015

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  Phenotypic changes in bone marrow-derived murine macrophages cultured on PEG-based hydrogels activated or not by lipopolysaccharide.

Authors:  Aaron D Lynn; Stephanie J Bryant
Journal:  Acta Biomater       Date:  2010-07-30       Impact factor: 8.947

2.  Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis.

Authors:  Roberto D Valladares; Christophe Nich; Stefan Zwingenberger; Chenguang Li; Katherine R Swank; Emmanuel Gibon; Allison J Rao; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2013-10-07       Impact factor: 4.396

Review 3.  Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?

Authors:  Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

Review 4.  Calcium-Containing Crystals and Osteoarthritis: an Unhealthy Alliance.

Authors:  Richard Conway; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

Review 5.  Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.

Authors:  Tzu-hua Lin; Yasunobu Tamaki; Jukka Pajarinen; Heather A Waters; Deanna K Woo; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

6.  High and low molecular weight hyaluronic acid differentially influence macrophage activation.

Authors:  Jamie E Rayahin; Jason S Buhrman; Yu Zhang; Timothy J Koh; Richard A Gemeinhart
Journal:  ACS Biomater Sci Eng       Date:  2015-07-13

7.  Collagen-hydroxyapatite composite enhances regeneration of calvaria bone defects in young rats but postpones the regeneration of calvaria bone in aged rats.

Authors:  Ion Tcacencu; Mikael Wendel
Journal:  J Mater Sci Mater Med       Date:  2007-10-19       Impact factor: 3.896

8.  Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.

Authors:  Rym Benabid; Julien Wartelle; Laurette Malleret; Nicolas Guyot; Sophie Gangloff; François Lebargy; Azzaq Belaaouaj
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

9.  Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice.

Authors:  Todd H Rogers; Julia E Babensee
Journal:  Biomaterials       Date:  2009-10-08       Impact factor: 12.479

10.  Curettage of benign bone tumors without grafts gives sufficient bone strength.

Authors:  Takashi Yanagawa; Hideomi Watanabe; Tetsuya Shinozaki; Kenji Takagishi
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.